Therapy-related myeloid neoplasms: when genetics and environment collide
ME McNerney, LA Godley, MM Le Beau - Nature Reviews Cancer, 2017 - nature.com
Therapy-related myeloid neoplasms (t-MN) arise as a late effect of chemotherapy and/or
radiation administered for a primary condition, typically a malignant disease, solid organ …
radiation administered for a primary condition, typically a malignant disease, solid organ …
[HTML][HTML] Long-term toxicity of cisplatin in germ-cell tumor survivors
M Chovanec, MA Zaid, N Hanna, N El-Kouri… - Annals of …, 2017 - Elsevier
Context Testicular germ-cell tumors (GCT) are highly curable. A multidisciplinary approach,
including cisplatin-based chemotherapy has resulted in cure in the majority of patients with …
including cisplatin-based chemotherapy has resulted in cure in the majority of patients with …
AAPM TG 158: measurement and calculation of doses outside the treated volume from external‐beam radiation therapy
The introduction of advanced techniques and technology in radiotherapy has greatly
improved our ability to deliver highly conformal tumor doses while minimizing the dose to …
improved our ability to deliver highly conformal tumor doses while minimizing the dose to …
Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk
FA Van Nimwegen, M Schaapveld… - JAMA internal …, 2015 - jamanetwork.com
Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …
diseases. It is unclear, however, how long the increased risk persists and what the risk …
[HTML][HTML] Mutational signatures of ionizing radiation in second malignancies
Ionizing radiation is a potent carcinogen, inducing cancer through DNA damage. The
signatures of mutations arising in human tissues following in vivo exposure to ionizing …
signatures of mutations arising in human tissues following in vivo exposure to ionizing …
Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study
DA Mulrooney, GT Armstrong, S Huang… - Annals of internal …, 2016 - acpjournals.org
Background: Studies of cardiac disease among adult survivors of childhood cancer have
generally relied on self-reported or registry-based data. Objective: To systematically assess …
generally relied on self-reported or registry-based data. Objective: To systematically assess …
Second malignant neoplasms: assessment and strategies for risk reduction
ME Wood, V Vogel, A Ng, L Foxhall… - Journal of clinical …, 2012 - ascopubs.org
Improvements in early detection, supportive care, and treatment have resulted in an
increasing number of cancer survivors, with a current 5-year relative survival rate for all …
increasing number of cancer survivors, with a current 5-year relative survival rate for all …
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
LB Travis, WD Wahnefried, JM Allan… - Nature reviews Clinical …, 2013 - nature.com
Second and higher-order malignancies now comprise about 18% of all incident cancers in
the USA, superseding first primary cancers of the breast, lung, and prostate. The occurrence …
the USA, superseding first primary cancers of the breast, lung, and prostate. The occurrence …
Ionizing radiation-induced oxidative stress, epigenetic changes and genomic instability: the pivotal role of mitochondria
I Szumiel - International journal of radiation biology, 2015 - Taylor & Francis
Purpose: To review the data concerning the role of endogenously generated reactive
oxygen species (ROS) in the non-targeted ionizing radiation (IR) effects and in …
oxygen species (ROS) in the non-targeted ionizing radiation (IR) effects and in …
Childhood cancer: occurrence, treatment and risk of second primary malignancies
S Zahnreich, H Schmidberger - Cancers, 2021 - mdpi.com
Simple Summary Childhood cancers are mostly of unknown etiology and represent
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …